by Matthew Johnson | Feb 27, 2020 | PTAB News
By Matt Johnson – The institution rate for post-grant challenges in current FY 2020 (Oct. 1, 2019 through January 31, 2020) stands at 56% compared to 63% in the previous fiscal year. While a relatively small sample size (204 instituted, 161 denied), this is a number...
by Matthew Johnson | Feb 18, 2020 | Federal Circuit Appeal, PTAB Trial Basics
By Sue Gerber and Matt Johnson – The Federal Circuit’s recent decision in Samsung Electronics America, Inc. v. Prisua Engineering Corp., — F.3d —, 2020 WL 543427, at *4 (Fed. Cir. Feb. 4. 2020), could not be more clear: “[W]e hold that the Board may...
by Matthew Johnson | Feb 14, 2020 | Amendment Practice, Request for Reconsideration
By Levent Herguner and Matt Johnson – In a recent decision, the PTAB admitted that it erred in its prior determination of unpatentability, and authorized supplemental briefing on the patentability of substitute claims. See Rimfrost AS v. Aker Biomarine...
by Matthew Johnson | Feb 13, 2020 | PTAB News
By Mike Lavine and Matt Johnson – On January 31, 2020, the Federal Circuit vacated and remanded a Patent Trial and Appeal Board (“PTAB”) final written decision in view of Arthrex, but did so reluctantly because it disagreed with the merits and questioned the...
by Matthew Johnson | Feb 10, 2020 | PTAB News
By Matt Johnson – The institution rate for post-grant challenges in current FY 2020 (Oct. 1, 2019 through December 31, 2019) stands at 55% compared to 63% in the previous fiscal year. While a small sample size (138 instituted, 113 denied), this is a number that we...
